{
    "title": "Bausch + Lomb buys Novartis drugs for $1.75 bln to boost eye-care portfolio",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12250925/Bausch--Lomb-buy-Novartis-dry-eye-drug-1-75-bln--WSJ.html",
    "date": "2023-06-30",
    "keywords": [
        "deal",
        "company",
        "year",
        "lomb",
        "market",
        "companys",
        "eye",
        "drug",
        "bausch",
        "care",
        "june",
        "friday",
        "trading",
        "acquisition",
        "novartis",
        "antiinflammation",
        "drop",
        "libvatrep",
        "surface",
        "pain",
        "pharma",
        "acustream",
        "delivery",
        "device",
        "ceo",
        "brent",
        "return",
        "march",
        "milestone",
        "end",
        "lombs",
        "miebo",
        "month",
        "dryeye",
        "condition",
        "behalf",
        "period",
        "supply",
        "approach",
        "respiratory",
        "immunology",
        "neuroscience",
        "oncology",
        "hematology",
        "payment",
        "treatment",
        "competition",
        "restasis",
        "copycat",
        "product",
        "lucentis",
        "degeneration",
        "cause",
        "blindness",
        "leo",
        "bengaluru",
        "burger",
        "frankfurt",
        "editing",
        "anil",
        "dsilva",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}